Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma

Cholangiocarcinoma (CCA), a group of malignancies that originate from the biliary tract, is associated with a high mortality rate and a concerning increase in worldwide incidence. In Thailand, where the incidence of CCA is the highest, the socioeconomic burden is severe. Yet, treatment options are l...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pharmaceuticals (Basel)
Päätekijät: Balasubramanian, Brinda, Venkatraman, Simran, Myint, Kyaw Zwar, Janvilisri, Tavan, Wongprasert, Kanokpan, Kumkate, Supeecha, Bates, David O., Tohtong, Rutaiwan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7826774/
https://ncbi.nlm.nih.gov/pubmed/33440754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14010051
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia